Ghrelin is a Prognostic Marker and a Potential Therapeutic Target in Breast Cancer

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2017 Apr 19

PMID 28419141

Citations 7

Authors

Malin Gronberg

Cecilia Ahlin

Ylva Naeser

Eva Tiensuu Janson

Lars Holmberg

Marie-Louise Fjallskog

Affiliations

Soon will be listed here.

Abstract

Ghrelin and obestatin are gastrointestinal peptides, encoded by the same preproghrelin gene. Both are expressed in breast cancer tissue and ghrelin has been implicated in breast cancer tumorigenesis. Despite recent advances in breast cancer management the need for new prognostic markers and potential therapeutic targets in breast cancer remains high. We studied the prognostic impact of ghrelin and obestatin in women with node negative breast cancer. Within a cohort of women with breast cancer with tumor size ≤ 50 mm, no lymph node metastases and no initiation of adjuvant chemotherapy, 190 women were identified who died from breast cancer and randomly selected 190 women alive at the corresponding time as controls. Tumor tissues were immunostained with antibodies versus the peptides. Ghrelin expression was associated with better breast cancer specific survival in univariate analyses (OR 0.55, 95% CI 0.36-0.84) and in multivariate models, adjusted for endocrine treatment and age (OR 0.57, 95% CI 0.36-0.89). Obestatin expression was non-informative (OR 1.2, 95% CI 0.60-2.46). Ghrelin expression is independent prognostic factor for breast cancer death in node negative patients-halving the risk for dying of breast cancer. Our data implies that ghrelin could be a potential therapeutic target in breast cancer treatment.

Citing Articles

Energy homeostasis genes modify the association between serum concentrations of IGF-1 and IGFBP-3 and breast cancer risk.

Rodriguez-Valentin R, Torres-Mejia G, Martinez-Matsushita L, Angeles-Llerenas A, Gomez-Flores-Ramos L, Wolff R Sci Rep. 2022; 12(1):1837.

PMID: 35115550 PMC: 8813998. DOI: 10.1038/s41598-022-05496-1.

Changes in Dietary Inflammatory Index Patterns with Weight Loss in Women: A Randomized Controlled Trial.

Duggan C, de Dieu Tapsoba J, Shivappa N, Harris H, Hebert J, Wang C Cancer Prev Res (Phila). 2020; 14(1):85-94.

PMID: 32859616 PMC: 7914258. DOI: 10.1158/1940-6207.CAPR-20-0181.

Ghrelin inhibits cisplatin-induced MDA-MB-231 breast cancer cell apoptosis via PI3K/Akt/mTOR signaling.

Zhang J, Xie T Exp Ther Med. 2020; 19(3):1633-1640.

PMID: 32104214 PMC: 7027091. DOI: 10.3892/etm.2019.8398.

Attribution of Ghrelin to Cancer; Attempts to Unravel an Apparent Controversy.

Soleyman-Jahi S, Sadeghi F, Khoshbin A, Khani L, Roosta V, Zendehdel K Front Oncol. 2019; 9:1014.

PMID: 31681567 PMC: 6805778. DOI: 10.3389/fonc.2019.01014.

No effect of unacylated ghrelin administration on subcutaneous PC3 xenograft growth or metabolic parameters in a Rag1-/- mouse model of metabolic dysfunction.

Maugham M, Seim I, Thomas P, Crisp G, Shah E, Herington A PLoS One. 2018; 13(11):e0198495.

PMID: 30458004 PMC: 6245673. DOI: 10.1371/journal.pone.0198495.

References

Jeffery P, Murray R, Yeh A, McNamara J, Duncan R, Francis G . Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines. Endocr Relat Cancer. 2005; 12(4):839-50. DOI: 10.1677/erc.1.00984. View

Nimeus-Malmstrom E, Koliadi A, Ahlin C, Holmqvist M, Holmberg L, Amini R . Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort. Int J Cancer. 2009; 127(4):961-7. DOI: 10.1002/ijc.25091. View

Zhang J, Ren P, Avsian-Kretchmer O, Luo C, Rauch R, Klein C . Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science. 2005; 310(5750):996-9. DOI: 10.1126/science.1117255. View

Gahete M, Rubio A, Cordoba-Chacon J, Gracia-Navarro F, Kineman R, Avila J . Expression of the ghrelin and neurotensin systems is altered in the temporal lobe of Alzheimer's disease patients. J Alzheimers Dis. 2010; 22(3):819-28. DOI: 10.3233/JAD-2010-100873. View

VanderWeele T, Hernan M, Robins J . Causal directed acyclic graphs and the direction of unmeasured confounding bias. Epidemiology. 2008; 19(5):720-8. PMC: 4242711. DOI: 10.1097/EDE.0b013e3181810e29. View

Seim I, Collet C, Herington A, Chopin L . Revised genomic structure of the human ghrelin gene and identification of novel exons, alternative splice variants and natural antisense transcripts. BMC Genomics. 2007; 8:298. PMC: 2014779. DOI: 10.1186/1471-2164-8-298. View

Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K . Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999; 402(6762):656-60. DOI: 10.1038/45230. View

Perks C, Holly J . Hormonal mechanisms underlying the relationship between obesity and breast cancer. Endocrinol Metab Clin North Am. 2011; 40(3):485-507, vii. DOI: 10.1016/j.ecl.2011.05.010. View

Costantini V, Vicentini E, Sabbatini F, Valerio E, Lepore S, Tessari M . GSK1614343, a novel ghrelin receptor antagonist, produces an unexpected increase of food intake and body weight in rodents and dogs. Neuroendocrinology. 2011; 94(2):158-68. DOI: 10.1159/000328968. View

10.

Dossus L, McKay J, Canzian F, Wilkening S, Rinaldi S, Biessy C . Polymorphisms of genes coding for ghrelin and its receptor in relation to anthropometry, circulating levels of IGF-I and IGFBP-3, and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and.... Carcinogenesis. 2008; 29(7):1360-6. DOI: 10.1093/carcin/bgn083. View

11.

Elston C, Ellis I . Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991; 19(5):403-10. DOI: 10.1111/j.1365-2559.1991.tb00229.x. View

12.

Garcia J, Swerdloff R, Wang C, Kyle M, Kipnes M, Biller B . Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab. 2013; 98(6):2422-9. PMC: 4207947. DOI: 10.1210/jc.2013-1157. View

13.

Gronberg M, Tsolakis A, Magnusson L, Janson E, Saras J . Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands. J Histochem Cytochem. 2008; 56(9):793-801. PMC: 2516956. DOI: 10.1369/jhc.2008.951145. View

14.

Ahlin C, Aaltonen K, Amini R, Nevanlinna H, Fjallskog M, Blomqvist C . Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values?. Histopathology. 2007; 51(4):491-8. DOI: 10.1111/j.1365-2559.2007.02798.x. View

15.

Gourcerol G, Million M, Adelson D, Wang Y, Wang L, Rivier J . Lack of interaction between peripheral injection of CCK and obestatin in the regulation of gastric satiety signaling in rodents. Peptides. 2006; 27(11):2811-9. DOI: 10.1016/j.peptides.2006.07.012. View

16.

Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe D . Adiponectin and breast cancer risk. J Clin Endocrinol Metab. 2004; 89(3):1102-7. DOI: 10.1210/jc.2003-031804. View

17.

Korbonits M, Goldstone A, Gueorguiev M, Grossman A . Ghrelin--a hormone with multiple functions. Front Neuroendocrinol. 2004; 25(1):27-68. DOI: 10.1016/j.yfrne.2004.03.002. View

18.

Schally , VARGA . Antagonistic Analogs of Growth Hormone-releasing Hormone: New Potential Antitumor Agents. Trends Endocrinol Metab. 1999; 10(10):383-391. DOI: 10.1016/s1043-2760(99)00209-x. View

19.

Gronberg M, Fjallskog M, Jirstrom K, Janson E . Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer. Acta Oncol. 2011; 51(3):386-93. DOI: 10.3109/0284186X.2011.631576. View

20.

Ahlin C, Zhou W, Holmqvist M, Holmberg L, Nilsson C, Jirstrom K . Cyclin A is a proliferative marker with good prognostic value in node-negative breast cancer. Cancer Epidemiol Biomarkers Prev. 2009; 18(9):2501-6. DOI: 10.1158/1055-9965.EPI-09-0169. View